A correlation between DDIT4 expression and poor survival was found in specific tumor types including ovarian cancer [23], breast cancer [24], lung cancer [25], and bladder urothelial carcinoma [26], which suggests that DDIT4 may be a cancer related protein and potential biomarker. Here, DDIT4 is linked to breast carcinoma.